HRTX
HERON THERAPEUTICS, INC. /DE/
NASDAQ · Healthcare · Biotechnology · US
$0.31
−1.90%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.77x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.51x
- Price / sales
- 0.39x
- Price / cash flow
- -5.07x
Enterprise value
- Enterprise value
- $165.5M
- EV / sales
- 1.09x
- EV / EBITDA
- -5.95x
- EV / EBIT
- -15.24x
- Market cap
- $58.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026